The RSV F p27 peptide: current knowledge, important questions

Wanderson Rezende1,2, Hadley E Neal3, Rebecca E Dutch3

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.

PubMed

Insights

Respiratory syncytial virus (RSV) causes severe illness in children and older adults. This review explores unanswered questions about how RSV enters cells and how its fusion protein (F) triggers this process, focusing on a key peptide called p27.

Area of Science:

  • Virology
  • Vaccinology
  • Molecular Biology

Background:

  • Respiratory syncytial virus (RSV) is a major global health concern, leading to significant hospitalizations and mortality in vulnerable populations.
  • Current vaccine development efforts primarily focus on the viral fusion (F) protein, a key target for preventing RSV infection.
  • The precise mechanisms governing RSV cell entry, F protein triggering, and subsequent fusion promotion remain incompletely understood.

Purpose of the Study:

  • To review and highlight critical unanswered questions regarding the molecular mechanisms of RSV entry.
  • To examine the role and triggering of the RSV F protein in viral fusion.
  • To specifically investigate the significance of the cleaved 27-amino acid peptide (p27) within the F protein.

Main Methods:

  • Literature review of existing research on RSV fusion mechanisms.
  • Analysis of studies focusing on the RSV F protein structure and function.
  • Examination of data pertaining to peptide fragments of the F protein, including p27.

Main Results:

  • Identified gaps in knowledge concerning the precise sequence of events in RSV F protein activation.
  • Highlighted the potential importance of the p27 peptide in regulating F protein conformational changes.
  • Underscored the need for further investigation into how p27 influences viral fusion efficacy.

Conclusions:

  • Further research is essential to elucidate the complete mechanism of RSV cell entry.
  • Understanding the role of p27 is crucial for developing more effective RSV vaccines.
  • Addressing these knowledge gaps may lead to improved strategies for controlling RSV-associated disease.